癌症是一种严重的疾病,2022年,全球造成989万人死亡。一种令人担忧的癌症是骨癌,比如骨肉瘤和尤因肿瘤,这在婴儿中更常见。这项研究显示了对使用氧化石墨烯及其衍生物治疗骨癌的积极兴趣。我们提出了一个系统的综述,分析了与使用GO治疗骨肉瘤相关的现有技术,通过对现有文献的评价。在这个意义上,综述了基于GO的纳米材料对骨肉瘤的潜在应用的研究,这表明,使用基于GO的纳米材料有很好的趋势,基于它们的热和抗癌活性,用于通过各种治疗方法治疗骨肉瘤。然而,需要更多的研究来开发高效的局部疗法。有人建议,因此,光动力疗法,光热疗法,纳米载体的使用应该被认为是非侵入性的,更具体,和治疗骨肉瘤的有效替代方案。这些选择提供了有希望的方法来增强治疗的有效性,同时还寻求减少副作用和最小化对周围健康组织的损伤。2004年1月至2022年12月对氧化石墨烯和还原氧化石墨烯的光热和光化学处理的文献计量分析,以其搜索策略提取了948篇文献,主要与研究论文有关,审查文件,和会议文件,证明了一个高影响力的领域,需要更多的选择性和有效的骨癌治疗。领导这项研究的中心国家是美国,伊朗,意大利,德国,中国,韩国,澳大利亚,与世界各地的强大合作。同时,被引用最多的论文发表在影响因子超过6.0(2021年)的期刊上,超过290次引用。此外,在该主题上发表最多的期刊是高影响因子期刊,根据所进行的分析,展示了该研究领域的巨大影响力。
Cancer is a severe disease that, in 2022, caused more than 9.89 million deaths worldwide. One worrisome type of cancer is bone cancer, such as osteosarcoma and Ewing tumors, which occur more frequently in infants. This study shows an active interest in the use of graphene oxide and its derivatives in therapy against bone cancer. We present a systematic
review analyzing the current state of the art related to the use of GO in treating osteosarcoma, through evaluating the existing literature. In this sense, studies focused on GO-based nanomaterials for potential applications against osteosarcoma were reviewed, which has revealed that there is an excellent trend toward the use of GO-based nanomaterials, based on their thermal and anti-cancer activities, for the treatment of osteosarcoma through various therapeutic approaches. However, more research is needed to develop highly efficient localized therapies. It is suggested, therefore, that photodynamic therapy, photothermal therapy, and the use of nanocarriers should be considered as non-invasive, more specific, and efficient alternatives in the treatment of osteosarcoma. These options present promising approaches to enhance the effectiveness of therapy while also seeking to reduce side effects and minimize the damage to surrounding healthy tissues. The bibliometric analysis of photothermal and photochemical treatments of graphene oxide and reduced graphene oxide from January 2004 to December 2022 extracted 948 documents with its search strategy, mainly related to research papers,
review papers, and conference papers, demonstrating a high-impact field supported by the need for more selective and efficient bone cancer therapies. The central countries leading the research are the United States, Iran, Italy, Germany, China, South Korea, and Australia, with strong collaborations worldwide. At the same time, the most-cited papers were published in journals with impact factors of more than 6.0 (2021), with more than 290 citations. Additionally, the journals that published the most on the topic are high impact factor journals, according to the analysis performed, demonstrating the high impact of the research field.